Does GILTERITINIB Cause Decreased appetite? 33 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 33 reports of Decreased appetite have been filed in association with GILTERITINIB (Xospata). This represents 0.9% of all adverse event reports for GILTERITINIB.
33
Reports of Decreased appetite with GILTERITINIB
0.9%
of all GILTERITINIB reports
8
Deaths
22
Hospitalizations
How Dangerous Is Decreased appetite From GILTERITINIB?
Of the 33 reports, 8 (24.2%) resulted in death, 22 (66.7%) required hospitalization, and 1 (3.0%) were considered life-threatening.
Is Decreased appetite Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GILTERITINIB. However, 33 reports have been filed with the FAERS database.
What Other Side Effects Does GILTERITINIB Cause?
Acute myeloid leukaemia (366)
Febrile neutropenia (346)
Off label use (334)
Platelet count decreased (327)
Pneumonia (302)
Myelosuppression (300)
Pyrexia (281)
Death (206)
Product use issue (189)
Hepatic function abnormal (181)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which GILTERITINIB Alternatives Have Lower Decreased appetite Risk?
GILTERITINIB vs GIMERACIL\OTERACIL\TEGAFUR
GILTERITINIB vs GINKGO
GILTERITINIB vs GIVINOSTAT
GILTERITINIB vs GIVOSIRAN
GILTERITINIB vs GLASDEGIB